<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02379988</url>
  </required_header>
  <id_info>
    <org_study_id>1409500149</org_study_id>
    <nct_id>NCT02379988</nct_id>
  </id_info>
  <brief_title>Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy</brief_title>
  <official_title>Pilot Study For Prone Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast Radiotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Arizona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Arizona</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pilot study to determine whether the addition of inspiratory hold (breath holding)&#xD;
      can decrease the radiation dose that the heart and lung receive for patients being treated&#xD;
      for left sided breast cancer.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Subjects have a standard of care CT simulation, which includes an additional breath hold CT.&#xD;
      Inspiratory gated breath-hold will be used. Two radiation plans will be generated: one for&#xD;
      the CT scan performed free breathing, and one for the CT scan performed with inspiratory&#xD;
      gated breath hold. The cardiac and lung doses will be determined. At the discretion of the&#xD;
      treating physician, the plan with the lower cardiac and lung dose may be used to treat the&#xD;
      patient.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 6, 2014</start_date>
  <completion_date type="Actual">May 17, 2021</completion_date>
  <primary_completion_date type="Actual">May 17, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The radiation dose in Gy to the heart and lung using two radiation techniques.</measure>
    <time_frame>15 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in the mean dose to the heart and lungs with prone breath hold.</measure>
    <time_frame>15 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Heart volume receiving 20 Gy, maximum dose to left ventricle/LAD artery.</measure>
    <time_frame>15 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relative volumes of lung receiving 20 Gy.</measure>
    <time_frame>15 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Verify radiation dose to heart and lung</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will undergo the standard of care CT simulation, which includes an additional breath hold CT. Inspiratory gated breath-hold will be used. Two radiation plans will be generated: one for the CT scan performed free breathing, and one for the CT scan performed with inspiratory gated breath hold. The cardiac and lung doses will be determined. At the discretion of the treating physician, the plan with the lower cardiac and lung dose may be used to treat the patient.</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>Verify radiation dose to heart and lung</intervention_name>
    <description>This is a pilot study to determine whether the addition of inspiratory hold (breath holding) can decrease the radiation dose that the heart and lung receives for patients being treated for left sided breast cancer.</description>
    <arm_group_label>Verify radiation dose to heart and lung</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients of Dr. Gonzalez&#xD;
&#xD;
          -  â‰¥18 years of age&#xD;
&#xD;
          -  Node-negative left breast cancer&#xD;
&#xD;
          -  Invasive or DCIS breast cancer&#xD;
&#xD;
          -  Prior lumpectomy&#xD;
&#xD;
          -  Deemed appropriate for treatment in the prone position by the treating physician&#xD;
&#xD;
          -  Able to tolerate prone position and breath hold during CT simulation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  &lt;18 years of age&#xD;
&#xD;
          -  Patients requiring treatment in supine position&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victor J Gonzalez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arizona Radiation Oncology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Uma Goyal, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Arizona Radiation Oncology</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Radiation Oncology Department at the University of Arizona Heath Network</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85724-5024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>January 26, 2015</study_first_submitted>
  <study_first_submitted_qc>February 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 5, 2015</study_first_posted>
  <last_update_submitted>June 21, 2021</last_update_submitted>
  <last_update_submitted_qc>June 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

